TIP comes to the East Coast

FAI's website announces a New Jersey location opening 15 September 2026 — the program's first clinic outside Southern California, joining its Long Beach headquarters and Vista/San Diego offices. It is a milestone for a clinic where, per family accounts in public threads, more than 50% of patients have traveled from outside California, some flying in from Florida, Texas, New Jersey, New York, Minnesota, and even the UK and Australia every 8–12 weeks. Exact address, intake process, and opening capacity are the kind of pre-launch details that shift, so confirm them with the clinic directly rather than relying on any secondhand page, including this one.

FAI publishes one national price structure: $979 a month for ages 18–25 and $1,079 a month for ages 26–50, with a 6-month minimum, and the subscription excludes food dosing replacements, SLIT materials, and some labs. The clinic's own cost page estimates a first year at roughly $11,748 on the cash path or about $15,425 on the insurance path. Patient reports run in the same territory — one family described roughly $15,000 all-in the first year and about $12,000 the second; another budgeted approximately $4,500 a year in guaranteed costs plus blood tests and co-pays. Nothing published suggests New Jersey pricing will differ, but nothing confirms it either, so ask for the full multi-year cost in writing — including the roughly $4,000 annual maintenance fee some families report after reaching remission, which several describe as not disclosed upfront. [The cost page](/learn/food-allergy-institute-cost) walks through every figure with sources.

This is one of the most important questions to ask, because FAI's published insurer list is California-flavored: Aetna, Anthem Blue Cross, Cigna, Blue Shield of California, and Health Net, with PPO plans only — no Kaiser, no HMOs. Blue Shield of California and Health Net do not translate directly to New Jersey networks, so families should ask specifically which NJ and NY plans the new clinic will bill in-network. Worth knowing: families report that the United Healthcare Grant has helped cover costs and does not require actually having UHC insurance. Get the answer in writing before the first visit, because one Birdeye reviewer described a nearly $10,000 insurance bill for in-house blood testing — a single attributed account, but the kind that makes written confirmation cheap insurance.

Historically, yes — and long. Journalism from 2019 counted roughly 1,350 families waiting about 13 months, and parents from the 2018–2021 era describe waits of 1.5 to 2 years. FAI publishes no current waitlist figure. A new location could relieve that pressure or simply inherit it: East Coast families already in the Long Beach pipeline may get transfer priority, or the New Jersey list may open fresh. Ask directly how the new clinic's intake is being seeded and where a new family would actually land in line.

Latitude already runs four established New York-area locations — Manhattan, Brooklyn, Long Island, and White Plains — with published in-network insurer lists for NY (Aetna, Anthem, Empire BlueCross, Cigna, Oxford, UnitedHealthcare). Its model is different: multi-allergen OIT reaching maintenance in 6–12 months (average about 8.4 months), followed by lifelong maintenance dosing, versus TIP's proprietary SLIT-plus-OIT protocol running 2.5–4 years toward a 'food freedom' endpoint. Latitude's one-time program fee is not published; patients report $4,000 to over $5,000 depending on region, while diagnostics and visits are typically billed in-network. Latitude publishes internal outcome figures — 94% of all ages and 98% of under-4s achieving desensitization — while FAI claims 99% success after completing TIP, a figure academic allergists questioned in Undark's 2021 reporting. [The comparison page](/learn/food-allergy-institute-vs-latitude) lays the two side by side.

The questions specific to newness: which clinicians will run New Jersey and how long they trained on the protocol at Long Beach; whether complex cases still route to California; whether the full diagnostic workup — FAI advertises 130+ allergens assessed — happens on-site or ships through the affiliated labs; and whether visit cadence matches the 4–6 in-person visits a year the program publishes. None of this implies anything is wrong. A new location of an established program is usually fine — but 'usually' is exactly what a written answer beats, especially for a multi-year commitment north of $10,000 a year.

No — and neither is anything else in this market. Since Palforzia was withdrawn from the US market on 31 July 2026, no FDA-approved food immunotherapy exists at all; every program, clinic-based or at-home, Curex's included, is prescribed off-label. Off-label does not mean unsafe — it is how most food allergy treatment has always been delivered. Patients have reported the clinic saying its method is 'under FDA review'; skeptics note a practice protocol is not a product the FDA reviews, and we cannot verify either way. The only FDA-approved food allergy medication is Xolair (February 2024, ages 1+), which reduces reaction severity on accidental exposure but does not desensitize. [The treatment options page](/learn/food-allergy-treatment-options) maps the post-Palforzia landscape.

Then the opening changes little, and the at-home route is the one that works in every zip code. Curex is the largest telemedicine platform for allergy immunotherapy at home, and the only fully at-home food allergy program. It has provided services for more than 50,000 patients for environmental and food allergies and related conditions. Testing runs through local labs, at-home phlebotomy or self-collection kits, doctors see patients by video visit or text, and a licensed compounding pharmacy ships the drops; $199 per month, environmental allergy plans from $79 per month, typically more than $10,000 saved over a course. The map explains why: one clinic serves one metro area; the FAST OIT directory lists clinics in 35 states, leaving 15 states plus DC with none listed at all, and a Midwest study found a median 57.3 miles to the nearest allergist of any kind. When 67 patients were offered commercial peanut OIT in a published study, 52% declined, with time burden the top reason at 28.5%. If you want the sublingual route with an in-person first visit, Allergy Associates of La Crosse in Onalaska, Wisconsin is one trip for the first visit, with rechecks every three to six months that can be virtual.